KRX Growth Companies With High Insider Ownership

In the last week, the South Korean market has stayed flat, yet it has risen 3.4% over the past 12 months with earnings forecasted to grow by 29% annually. In this context, identifying growth companies with high insider ownership can be particularly promising as insiders often have a deep understanding of their company's potential and are committed to its long-term success.

Top 10 Growth Companies With High Insider Ownership In South Korea

Name	Insider Ownership	Earnings Growth
People & Technology (KOSDAQ:A137400)	16.5%	35%
Fine M-TecLTD (KOSDAQ:A441270)	17.1%	36.4%
Global Tax Free (KOSDAQ:A204620)	18.1%	72.4%
Seojin SystemLtd (KOSDAQ:A178320)	29.8%	58.7%
Park Systems (KOSDAQ:A140860)	33%	36.6%
Vuno (KOSDAQ:A338220)	19.5%	105%
UTI (KOSDAQ:A179900)	33.1%	122.7%
INTEKPLUS (KOSDAQ:A064290)	16.3%	77.4%
HANA Micron (KOSDAQ:A067310)	20%	97.4%
Techwing (KOSDAQ:A089030)	18.7%	77.8%

Click here to see the full list of 81 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

JUSUNG ENGINEERINGLtd (KOSDAQ:A036930)

Simply Wall St Growth Rating: ★★★★★☆

Overview: JUSUNG ENGINEERING Co., Ltd. manufactures and sells semiconductor, display, solar, and lighting equipment in South Korea and internationally, with a market cap of ₩1.36 billion.

Operations: The company's revenue segments include semiconductor equipment and services, generating ₩272.61 billion.

Insider Ownership: 36.8%

Earnings Growth Forecast: 37.8% p.a.

JUSUNG ENGINEERING Ltd. is trading 25.2% below its estimated fair value and analysts expect the stock price to rise by 68.6%. The company's revenue is forecast to grow at 25.2% per year, significantly outpacing the market's growth rate of 10.1%, while earnings are projected to increase by 37.8% annually, exceeding the market average of 29.5%. However, profit margins have decreased from last year's figures due to large one-off items impacting financial results.

• Click here to discover the nuances of JUSUNG ENGINEERINGLtd with our detailed analytical future growth report.
• The valuation report we've compiled suggests that JUSUNG ENGINEERINGLtd's current price could be quite moderate.

Daejoo Electronic Materials (KOSDAQ:A078600)

Simply Wall St Growth Rating: ★★★★★★

Overview: Daejoo Electronic Materials Co., Ltd. develops and sells electronic materials across several regions including South Korea, China, Taiwan, the United States, Europe, and Southeast Asia with a market cap of ₩1.74 trillion.

Operations: The company's revenue segment primarily focuses on the development, production, and sale of electrical and electronic components, generating ₩193.79 billion.

Insider Ownership: 28.9%

Earnings Growth Forecast: 55.8% p.a.

Daejoo Electronic Materials, a growth company with high insider ownership, reported strong first-quarter earnings for 2024 with sales of KRW 46.30 million and net income of KRW 5.65 million, reversing a loss from the previous year. The company recently secured KRW 61 billion through private placements involving major investors like Samsung Securities and NH Investment & Securities. Despite its highly volatile share price, Daejoo's revenue is forecast to grow at an impressive rate of 39% annually, significantly outpacing the market average.

• Dive into the specifics of Daejoo Electronic Materials here with our thorough growth forecast report.
• In light of our recent valuation report, it seems possible that Daejoo Electronic Materials is trading beyond its estimated value.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc., a biotechnology company, specializes in developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars with a market cap of ₩16.73 billion.

Operations: The company's revenue segments include long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Insider Ownership: 26.6%

Earnings Growth Forecast: 72.9% p.a.

ALTEOGEN Inc. recently received MFDS approval for Tergase®, a recombinant hyaluronidase with over 99% purity, marking its transition to a commercial-stage company. Despite past shareholder dilution and high share price volatility, ALTEOGEN's revenue is forecast to grow at 48.7% annually, significantly outpacing the market average. Earnings are also expected to rise by 72.95% per year, supported by strong non-cash earnings and a projected very high return on equity of 45.2%.

• Get an in-depth perspective on ALTEOGEN's performance by reading our analyst estimates report here.
• Upon reviewing our latest valuation report, ALTEOGEN's share price might be too optimistic.

Taking Advantage

• Dive into all 81 of the Fast Growing KRX Companies With High Insider Ownership we have identified here.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com